#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Synovial sarcoma Glioblastoma Pemphigoid Carcinoid syndrome Immune-mediated enterocolitis Neoplasm Hairy cell leukaemia Congenital aplastic anaemia Squamous cell carcinoma of the vulva Dent's disease Primary immunodeficiency syndrome Acute graft versus host disease in intestine Prader-Willi syndrome Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Life with Disease Leiomyosarcoma – Basic Information Aicardi-Goutieres syndrome – Basic Information Idiopathic inflammatory myopathy – Treatment Ewing’s sarcoma – Life with Disease Epidermolysis bullosa – Basic Information Chordoma – Trials in Disease Angiosarcoma recurrent – Trials in Disease Mantle cell lymphoma – Trials in Disease Undifferentiated sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atorvastatin Syn321 Ripretinib Specific Nucleic Acid Sna-Veru Cilazapril Epirubicin Hydrochloride Gentamicin Nmd670 Rilpivirine Hydrochloride Diclofenac Sodium Encorafenib Norfloxacin Tepotinib Bms-986442 S095035 HAFNIUM OXIDE Oleclumab Garetosmab Budesonide Lenacapavir More therapies…

    Learn about Your Condition

    Cervix carcinoma recurrent Nocturia Leukoencephalopathy Dent's disease Otitis media Lung cancer metastatic Cytomegalovirus infection ROHHAD syndrome Congenital myopathy Pleomorphic liposarcoma Idiopathic pulmonary fibrosis Neurodegenerative disorder Nephroblastoma Coronary artery disease Chronic hepatitis C More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Theageneio Cancer Hospital

Theageneio Cancer Hospital

Simeonidi Alex 2, Thessaloniki, 546 39, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Gemcitabine
    • Lenalidomide
    Belgium Bulgaria Croatia Czechia France Greece +5

  • Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium Denmark Finland France Germany +7

  • Study on the Effectiveness and Safety of Lazertinib and Gefitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma stage III
    • Lung adenocarcinoma stage IV
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Gefitinib
    • Lazertinib
    Greece Hungary

  • Study Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Carfilzomib
    • Dexamethasone
    Belgium Czechia Germany Greece Italy The Netherlands +2

  • Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Elranatamab
    Austria Belgium Czechia Finland France Germany +7

  • Study of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Treating Multiple Myeloma Patients with Extramedullary Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Cyclophosphamide
    • Daratumumab
    Greece Italy

  • Study of Cemiplimab and Chemotherapy Combination for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cemiplimab
    • Cisplatin
    France Greece Ireland Poland

  • Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Recombinant Human Interferon Gamma 1B
    Germany Greece The Netherlands Romania

  • Comparison of Sotorasib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer Patients with KRAS p.

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sotorasib
    • Dexamethasone
    • Docetaxel
    France Germany Greece Italy The Netherlands Poland +2

  • Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Betamethasone Sodium Phosphate Ph. Eur
    • Caffeine
    Czechia France Germany Greece Italy Poland +1
Previous Page
1 … 4 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!